丹农病基因治疗研究中一名临床试验参与者死亡，该研究由火箭制药公司进行Clinical Trial Participant Dies During Rocket Pharmaceuticals Gene Therapy Study for Danon Disease

动脉网2025-05-27

by Mark Chiang马克·蒋Share To分享到A participant in a clinical trial conducted by Rocket Pharmaceuticals for a gene therapy targeting a rare heart condition has died, according to information released by ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2538467455?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-27 22:13","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2538467455","market":"us","top_or_hot":-1,"title":"丹农病基因治疗研究中一名临床试验参与者死亡，该研究由火箭制药公司进行Clinical Trial Participant Dies During Rocket Pharmaceuticals Gene Therapy Study for Danon Disease","media":"动脉网","content":"<div>\n<p>by Mark Chiang马克·蒋Share To分享到A participant in a clinical trial conducted by Rocket Pharmaceuticals for a gene therapy targeting a rare heart condition has died, according to information released by ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722171195046e1a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>丹农病基因治疗研究中一名临床试验参与者死亡，该研究由火箭制药公司进行Clinical Trial Participant Dies During Rocket Pharmaceuticals Gene Therapy Study for Danon Disease</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n丹农病基因治疗研究中一名临床试验参与者死亡，该研究由火箭制药公司进行Clinical Trial Participant Dies During Rocket Pharmaceuticals Gene Therapy Study for Danon Disease\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-27 22:13 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722171195046e1a&s=b><strong>动脉网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>by Mark Chiang马克·蒋Share To分享到A participant in a clinical trial conducted by Rocket Pharmaceuticals for a gene therapy targeting a rare heart condition has died, according to information released by ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722171195046e1a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722171195046e1a&s=b","article_id":"2538467455","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722171195046e1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2538467455","pubTimestamp":1748355180,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"Rocket Pharmaceuticals disclosed the death but did not provide specific details regarding the circumstances surrounding it or whether it was directly related to the experimental treatment. Danon disease is known for its severe impact on cardiac function, often leading to life-threatening complications.Rocket Pharmaceuticals 披露了这起死亡事件，但未提供有关其具体情况或是否与实验性治疗直接相关的细节。随着对这一事件调查的继续，预计火箭制药公司将提供更多更新。Generic Drug Developers Urged to Prioritize Pharmacovigilance Amidst Concerns Over Medication Errors Causing 400,000 U.S. Deaths Annually仿制药开发商被敦促优先重视药物警戒，此前有担忧称用药错误每年导致美国40万人死亡。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","RCKT":"Rocket Pharmaceuticals, Inc."},"translate_title":"Death of a clinical trial participant in Dannon's disease gene therapy study conducted by Rocket Pharmaceuticals Clinical Trial Participant Dies During Rocket Pharmaceuticals Gene Therapy Study for Danon Disease","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RCKT":0.9},"content_text":"by Mark Chiang马克·蒋Share To分享到A participant in a clinical trial conducted by Rocket Pharmaceuticals for a gene therapy targeting a rare heart condition has died, according to information released by the company. The trial is focused on treating Danon disease, an inherited disorder that affects the heart and other organs.据该公司发布的信息，火箭制药公司进行的一项针对罕见心脏疾病的基因治疗临床试验中的一名参与者死亡。该试验的重点是治疗丹侬病，一种影响心脏和其他器官的遗传性疾病。Rocket Pharmaceuticals disclosed the death but did not provide specific details regarding the circumstances surrounding it or whether it was directly related to the experimental treatment. Danon disease is known for its severe impact on cardiac function, often leading to life-threatening complications.Rocket Pharmaceuticals 披露了这起死亡事件，但未提供有关其具体情况或是否与实验性治疗直接相关的细节。Danon 病以其对心脏功能的严重影响而闻名，常导致危及生命的并发症。The company had been testing its investigational gene therapy as part of ongoing efforts to address this rare condition. Further updates from Rocket Pharmaceuticals are anticipated as investigations into the incident continue..该公司一直在测试其研究性基因疗法，作为解决这一罕见疾病持续努力的一部分。随着对这一事件调查的继续，预计火箭制药公司将提供更多更新。Newsflash | Powered by GeneOnline AI新闻快讯 | 由GeneOnline AI提供支持Source: GO-AI-ne1来源：GO-AI-ne1Date: May 27, 2025日期：2025年5月27日Related posts:相关文章：Google Patents: Access Millions of Worldwide Patents for Pharmaceutical Industry Developments谷歌专利：获取数百万项全球制药行业发展的专利Generic Drug Supply Chain Modernization Aims for Efficiency, Prioritizing Real-Time Visibility of Inventory and Shipping.通用药物供应链现代化旨在提高效率，优先实现库存和运输的实时可见性。Generic Drug Developers Urged to Prioritize Pharmacovigilance Amidst Concerns Over Medication Errors Causing 400,000 U.S. Deaths Annually仿制药开发商被敦促优先重视药物警戒，此前有担忧称用药错误每年导致美国40万人死亡。Calquence Combination Therapy Reduces Disease Progression or Death Risk by 27% in Phase III TrialCalquence联合疗法在III期试验中将疾病进展或死亡风险降低了27%©www.geneonline.com All rights reserved. Collaborate with us:©www.geneonline.com 版权所有。与我们合作：[email protected][email protected]Author作者Mark Chiang马克·蒋Related Post相关文章News Flash新闻快报University of Würzburg Study Links Genetic Mutations and Imprinting Errors to Wilms Tumor Development in Children维尔茨堡大学研究将基因突变和印记错误与儿童肾母细胞瘤的发展联系起来2025-05-272025年5月27日","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2538467455","isCrawlerRequest":true}